NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 34 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 135,834,000 | $118,179,303 | 3.86% |
| STEELHEAD PARTNERS LLC | 50,000,000 | $43,056,250 | 2.73% |
| DeepCurrents Investment Group LLC | 45,000,000 | $38,654,893 | 1.53% |
| Opti Capital Management, LP | 18,000,000 | $15,570,000 | 1.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,557,000 | $50,549,274 | 0.60% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,856,000 | $4,168,602 | 0.59% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,180,000 | $6,246,794 | 0.49% |
| Context Capital Management, LLC | 4,489 | $3,906 | 0.35% |
| LINDEN ADVISORS LP | 37,025,000 | $31,949,534 | 0.34% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 14,000,000 | $12,091,110 | 0.25% |